Global Substance Abuse Therapeutics Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Substance Abuse Therapeutics Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application
Substance Abuse can be defined as habitually, dependence of an individual on any drugs, which turns into an addiction. Opioid, alcohol, tobacco and cigarettes are some of the common, drugs which has been misused leading to drugs addictions. In recent past, many products have been launched in market for treatment and management of substance abuse. Some commonly used drug for treatment of substance abuse are Disulfiram, Acamprosate, Naltrexone, Nicotine Replacement Treatment, Methadone, and Buprenorphine.
Substance Abuse Therapeutics report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Substance Abuse Therapeutics market is projected to reach US$ 27740 million in 2034, increasing from US$ 17840 million in 2022, with the CAGR of 6.4% during the period of 2024 to 2034. Demand from Hospital & Clinics and Residential (non-hospital) are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Substance Abuse Therapeutics industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Substance Abuse Therapeutics key companies include Indivior, Pfizer, Alkermes, Novartis, Mylan, Cipla, Glenmark, Dr. Reddy's Laboratories and Teva Pharmaceutical, etc. Indivior, Pfizer, Alkermes are top 3 players and held % share in total in 2022.
Substance Abuse Therapeutics can be divided into Opioid Addiction, Tobacco/Nicotine Addiction and Alcohol Dependence,, etc. Opioid Addiction is the mainstream product in the market, accounting for % share globally in 2022.
Substance Abuse Therapeutics is widely used in various fields, such as Hospital & Clinics and Residential (non-hospital), etc. Hospital & Clinics provides greatest supports to the Substance Abuse Therapeutics industry development. In 2022, global % share of Substance Abuse Therapeutics went into Hospital & Clinics filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Substance Abuse Therapeutics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Indivior
Pfizer
Alkermes
Novartis
Mylan
Cipla
Glenmark
Dr. Reddy's Laboratories
Teva Pharmaceutical
Segment by Type
Opioid Addiction
Tobacco/Nicotine Addiction
Alcohol Dependence
Hospital & Clinics
Residential (non-hospital)
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Substance Abuse Therapeutics market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Substance Abuse Therapeutics introduction, etc. Substance Abuse Therapeutics Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Substance Abuse Therapeutics market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Substance Abuse Therapeutics report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Substance Abuse Therapeutics market is projected to reach US$ 27740 million in 2034, increasing from US$ 17840 million in 2022, with the CAGR of 6.4% during the period of 2024 to 2034. Demand from Hospital & Clinics and Residential (non-hospital) are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Substance Abuse Therapeutics industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Substance Abuse Therapeutics key companies include Indivior, Pfizer, Alkermes, Novartis, Mylan, Cipla, Glenmark, Dr. Reddy's Laboratories and Teva Pharmaceutical, etc. Indivior, Pfizer, Alkermes are top 3 players and held % share in total in 2022.
Substance Abuse Therapeutics can be divided into Opioid Addiction, Tobacco/Nicotine Addiction and Alcohol Dependence,, etc. Opioid Addiction is the mainstream product in the market, accounting for % share globally in 2022.
Substance Abuse Therapeutics is widely used in various fields, such as Hospital & Clinics and Residential (non-hospital), etc. Hospital & Clinics provides greatest supports to the Substance Abuse Therapeutics industry development. In 2022, global % share of Substance Abuse Therapeutics went into Hospital & Clinics filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Substance Abuse Therapeutics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Indivior
Pfizer
Alkermes
Novartis
Mylan
Cipla
Glenmark
Dr. Reddy's Laboratories
Teva Pharmaceutical
Segment by Type
Opioid Addiction
Tobacco/Nicotine Addiction
Alcohol Dependence
Segment by Application
Hospital & Clinics
Residential (non-hospital)
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Substance Abuse Therapeutics market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Substance Abuse Therapeutics introduction, etc. Substance Abuse Therapeutics Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Substance Abuse Therapeutics market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices